Fill Out Your Profile to share more about you. Learn more...

FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers

Options

FDA Approves Truqap for Certain Metastatic, Hormone Receptor-Positive Breast Cancers

Nov 17, 2023

Truqap is a new targeted therapy option for metastatic, hormone receptor-positive breast cancer with specific genetic mutations that has stopped responding to other hormonal therapy medicines. Read more…

q